AAAAAA
Results:
1-23
|
Results: 23
Authors:
Craxi, A
Di Marco, V
Citation: A. Craxi et V. Di Marco, Treatment of hepatitis D, GASTR HEPAT, 8, 2002, pp. 319-345
Authors:
Schepis, F
Camma, C
Niceforo, D
Magnano, A
Pallio, S
Cinquegrani, M
D'Amico, G
Pasta, L
Craxi, A
Saitta, A
Raimondo, G
Citation: F. Schepis et al., Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?, HEPATOLOGY, 33(2), 2001, pp. 333-338
Authors:
Di Marco, V
Vaccaro, A
Ferraro, D
Alaimo, G
Rodolico, V
Parisi, P
Peralta, S
Di Stefano, R
Almasio, PL
Craxi, A
Citation: V. Di Marco et al., High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C, ALIM PHARM, 15(7), 2001, pp. 953-958
Authors:
Izzo, V
Craxi, A
Barbieri, R
Citation: V. Izzo et al., Multiple voltage-gradient gel electrophoresis system, ELECTROPHOR, 22(1), 2001, pp. 29-32
Authors:
Craxi, A
Lo Iacono, O
Citation: A. Craxi et O. Lo Iacono, Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?, J HEPATOL, 35(4), 2001, pp. 527-530
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach
Authors:
Camma, C
Giunta, M
Andreone, P
Craxi, A
Citation: C. Camma et al., Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach, J HEPATOL, 34(4), 2001, pp. 593-602
Authors:
Gramenzi, A
Andreone, P
Fiorino, S
Camma, C
Giunta, M
Magalotti, D
Cursaro, C
Calabrese, C
Arienti, V
Rossi, C
Di Febo, G
Zoli, M
Craxi, A
Gasbarrini, G
Bernardi, M
Citation: A. Gramenzi et al., Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis, GUT, 48(6), 2001, pp. 843-848
Authors:
Raimondo, G
Balsano, C
Craxi, A
Farinati, F
Levrero, M
Mondelli, M
Pollicino, T
Squadrito, G
Tiribelli, C
Citation: G. Raimondo et al., Occult hepatitis B virus infection, DIG LIVER D, 32(9), 2000, pp. 822-826
Authors:
Craxi, A
Camma, C
Giunta, M
Citation: A. Craxi et al., Clinical aspects of bleeding complications in cirrhotic patients, BL COAG FIB, 11, 2000, pp. S75-S79
Authors:
Prestileo, T
Mazzola, G
Di Lorenzo, F
Colletti, P
Vitale, F
Ferraro, D
Di Stefano, R
Camma, C
Craxi, A
Citation: T. Prestileo et al., Response-adjusted alpha-interferon therapy for chronic hepatitis C in HIV-infected patients, INT J ANT A, 16(3), 2000, pp. 373-378
Authors:
Almasio, PL
Floreani, A
Chiaramonte, M
Provenzano, G
Battezzati, P
Crosignani, A
Podda, M
Todros, L
Rosina, F
Saccoccio, G
Manenti, F
Ballardini, G
Bianchi, FP
Scheuer, PJ
Davies, SE
Craxi, A
Citation: Pl. Almasio et al., Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis, ALIM PHARM, 14(12), 2000, pp. 1645-1652
Authors:
Di Marco, V
Almasio, P
Vaccaro, A
Ferraro, D
Parisi, P
Cataldo, MG
Di Stefano, R
Craxi, A
Citation: V. Di Marco et al., Combined treatment of relapse of chronic hepatitis C with high-dose a(2)b interferon plus ribavirin for 6 or 12 months, J HEPATOL, 33(3), 2000, pp. 456-462
Authors:
Camma, C
Giunta, M
Fiorica, F
Pagliaro, L
Craxi, A
Cottone, M
Citation: C. Camma et al., Preoperative radiotherapy for resectable rectal cancer - A meta-analysis, J AM MED A, 284(8), 2000, pp. 1008-1015
Chronic hepatitis C: Interferon retreatment of relapsers. A meta-analysis of individual patient data
Authors:
Camma, C
Giunta, M
Chemello, L
Alberti, A
Toyoda, H
Trepo, C
Marcellin, P
Zahm, F
Schalm, S
Craxi, A
Citation: C. Camma et al., Chronic hepatitis C: Interferon retreatment of relapsers. A meta-analysis of individual patient data, HEPATOLOGY, 30(3), 1999, pp. 801-807
Authors:
Craxi, A
Mariani, G
Citation: A. Craxi et G. Mariani, Surgery in patients with liver disease, HEPATOLOGY, 30(3), 1999, pp. 820-820
Authors:
Janssen, HLA
Gerken, G
Carreno, V
Marcellin, P
Naoumov, NV
Craxi, A
Ring-Larsen, H
Kitis, G
van Hattum, J
de Vries, RA
Michielsen, PP
ten Kate, FJW
Hop, WCJ
Heijtink, RA
Honkoop, P
Schalm, SW
Citation: Hla. Janssen et al., Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment, HEPATOLOGY, 30(1), 1999, pp. 238-243
Authors:
Di Marco, V
Lo Iacono, O
Camma, C
Vaccaro, A
Giunta, M
Martorana, G
Fuschi, P
Almasio, PL
Craxi, A
Citation: V. Di Marco et al., The long-term course of chronic hepatitis B, HEPATOLOGY, 30(1), 1999, pp. 257-264
Authors:
Marcellin, P
Alberti, A
Dusheiko, G
Esteban, R
Manns, M
Shouval, D
Weiland, O
Williams, R
Benhamou, JP
Rodes, J
Alter, H
Bismuth, H
Desmet, V
Guardia, J
Heathcote, J
Lok, A
Maddrey, WC
Zum Buschenfelde, KHM
Pagliaro, L
Paumgartner, G
Sherlock, S
Abrignani, S
Alberti, A
Alter, M
Bonino, F
Bortolotti, F
Brechot, C
de Moura, MC
Carreno, V
Colombo, M
Craxi, A
Davis, G
De Francesco, R
Degos, F
Di Bisceglie, A
Dienes, H
Dusheiko, G
Esteban, J
Esteban, R
Farci, P
Ferrari, C
Foster, G
Hadziyannis, S
Hoofnagle, J
Koff, R
Lavanchy, D
Lindsay, K
Lunel, F
Manns, M
Marcellin, P
Mondelli, M
Nalpas, B
Naoumov, N
Pawlotsky, JM
Pol, S
Pontisso, P
Poynard, T
Prieto, J
Rizzetto, M
Roggendorf, M
Moreno, MR
Samuel, D
Sanchez-Tapias, J
Schalm, S
Shouval, D
Simmonds, P
Soriano, V
Tassopoulos, N
Thomas, H
Trepo, C
Van der Poel, CL
Vogel, W
Weiland, O
Wejstal, R
Williams, R
Wright, T
Zanetti, A
Zarski, JP
Zeuzem, S
Zoulim, F
Citation: P. Marcellin et al., EASL International Consensus Conference on Hepatitis C - Paris, 26-27 February 1999 - Consensus statement (Reprinted from Journal of Hematology, vol 30, pg 956-961, 1999), J HEPATOL, 31, 1999, pp. 3-8
Authors:
Craxi, A
Camma, C
Giunta, M
Citation: A. Craxi et al., Definition of response to antiviral therapy in chronic hepatitis C, J HEPATOL, 31, 1999, pp. 160-167
Authors:
Almasio, PL
Di Marco, V
Bonura, C
Fuschi, P
Camma, C
Lo Iacono, O
Artini, M
Natoli, C
Di Stefano, R
Levrero, M
Craxi, A
Citation: Pl. Almasio et al., Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferon, DIG DIS SCI, 44(5), 1999, pp. 1013-1019
Authors:
Stroffolini, T
Andreone, P
Andriulli, A
Ascione, A
Craxi, A
Chiaramonte, M
Galante, D
Manghisi, OG
Mazzanti, R
Medaglia, C
Pilleri, G
Rapaccini, GL
Albanese, M
Taliani, G
Tosti, ME
Villa, E
Gasbarrini, G
Citation: T. Stroffolini et al., Guess pathologic types of hepatocellular carcinoma in Italy, ONCOL-BASEL, 56(3), 1999, pp. 189-192
Authors:
Lo Iacono, O
Garcia-Monzon, C
Almasio, P
Garcia-Buey, L
Craxi, A
Moreno-Otero, R
Citation: O. Lo Iacono et al., Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha, ALIM PHARM, 12(11), 1998, pp. 1091-1099
Authors:
Stroffolini, T
Andreone, P
Andriulli, A
Ascione, A
Craxi, A
Chiaramonte, M
Galante, D
Manghisi, OG
Mazzanti, R
Medaglia, C
Pilleri, G
Rapaccini, GL
Simonetti, RG
Taliani, G
Tosti, ME
Villa, E
Gasbarrini, G
Citation: T. Stroffolini et al., Characteristics of hepatocellular carcinoma in Italy, J HEPATOL, 29(6), 1998, pp. 944-952
Risultati:
1-23
|